Lack of legislation regarding parallel imports of pharmaceutical products in Trinidad and Tobago
Trade barrier summary
Parallel imports negatively affect the UK pharmaceutical businesses' profits, and can put consumer's health at risk in the market. This is largely because some pharmaceuticals require special handling, storage and labelling, the absence of which can change the make-up of the pharmaceutical product, or reduce its effectiveness. Trinidad and Tobago laws state that once a product is registered in the local market, it can be imported and sold by anyone. This increases the number of unauthorised distributors selling a product, possibly at a cheaper price.
Sectors affected
- Pharmaceuticals and biotechnology
- Healthcare services
Resolved
No
Date reported
13 May 2019
Last updated
2 February 2021
Public ID
PID-G22WPG
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.